Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Shares Issued (2016 - 2025)

Prestige Consumer Healthcare (PBH) has 16 years of Shares Issued data on record, last reported at $752000.0 in Q3 2025.

  • For Q3 2025, Shares Issued fell 53.49% year-over-year to $752000.0; the TTM value through Dec 2025 reached $6.4 million, down 67.52%, while the annual FY2025 figure was $14.8 million, 18.17% down from the prior year.
  • Shares Issued reached $752000.0 in Q3 2025 per PBH's latest filing, down from $3.2 million in the prior quarter.
  • Across five years, Shares Issued topped out at $8.7 million in Q4 2024 and bottomed at $199000.0 in Q1 2023.
  • Average Shares Issued over 5 years is $2.9 million, with a median of $2.1 million recorded in 2023.
  • Peak YoY movement for Shares Issued: skyrocketed 7620.51% in 2021, then plummeted 84.95% in 2023.
  • A 5-year view of Shares Issued shows it stood at $3.0 million in 2021, then surged by 88.77% to $5.7 million in 2022, then crashed by 71.24% to $1.6 million in 2023, then surged by 435.05% to $8.7 million in 2024, then crashed by 91.4% to $752000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $752000.0 in Q3 2025, $3.2 million in Q2 2025, and $2.5 million in Q1 2025.